Featured Research

from universities, journals, and other organizations

179 million cases of acute diarrhea in U.S. each year, most preventable

Date:
April 22, 2014
Source:
University of Texas Health Science Center at Houston
Summary:
Approximately 179 million cases of acute diarrhea occur each year in the United States, and most of those cases are entirely preventable, a researcher concluded. The main causes of diarrheal infections include norovirus outbreaks and foodborne pathogens, with most coming from contaminated leafy green vegetables, he states.

"Consumers need to give their leafy greens a bath and a shower in order to make sure they are safe to eat," says DuPont, instructing that leafy greens must be soaked in a bowl of water or the sink and then rinsed thoroughly by running water through a colander before consumption in order to avoid contaminants.
Credit: oocoskun / Fotolia

In the United States, approximately 179 million cases of acute diarrhea occur each year, and most of those cases are entirely preventable, a researcher from The University of Texas Health Science Center at Houston (UTHealth) concluded in a New England Journal of Medicine review article.

Herbert L. DuPont, M.D., director of the Center for Infectious Diseases at the UTHealth School of Public Health, examined current causes, prevention strategies and treatment for acute diarrhea in healthy adults. He says the main causes of diarrheal infections include norovirus outbreaks and foodborne pathogens, with most coming from contaminated leafy green vegetables.

Produce is the most common source of diarrhea due to foodborne intestinal illness. Most consumers are not aware that 98 percent of spinach and lettuce bought from grocery stores is not inspected and much of it comes from developing countries. One study showed that of the 2 percent that is inspected, 40 percent failed inspection and could be contaminated by diarrhea-producing E. coli or Salmonella.

"Consumers need to give their leafy greens a bath and a shower in order to make sure they are safe to eat," says DuPont, instructing that leafy greens must be soaked in a bowl of water or the sink and then rinsed thoroughly by running water through a colander before consumption in order to avoid contaminants.

Noroviruses are the principal cause of diarrheal infections and are responsible for 50 percent of outbreaks due to the high potential for person-to-person spread. The outbreaks are particularly common in closed populations such as cruise ships, nursing homes, dormitories and hospitals. Eighty-three percent of deaths from acute diarrhea in the U.S. occur in adults ages 65 or older who have weaker immune systems and often are residing in closed populations.

"It's important for people who are experiencing symptoms to seek medical attention if they are sick longer than 48 hours, have fever or are passing bloody diarrhea," says DuPont.

Post-diarrheal health complications are major unappreciated concerns, DuPont says. After intestinal infection, a small number of people develop chronic conditions like arthritis, irritable bowel syndrome (IBS) or even autoimmune diseases like Guillain-Barre Syndrome, a form of paralysis. These complications usually affect people who have been exposed to pathogens that cause severe intestinal inflammation in people who are sicker, younger and for IBS, in those who are already dealing with depression or a chronic anxiety disorder.

DuPont says his analysis of current treatments for acute diarrhea shows a need for antibiotic treatment for certain infections. Most currently used drugs for diarrhea treat symptoms and ease pain, but these treatments do not shorten the illness. These drugs are of particular value for those who become ill while traveling to allow people to take bus trips or flights.

Clostridium difficile-associated diarrhea, or "C diff," is one of the most prevalent causes of fatal illness from diarrhea and usually emerges during or after a hospital stay in people who take antibiotics. Our current therapy for C diff is inadequate, with high rates of recurrent disease, says DuPont. He suggests developing vaccines to provide protection against C difficile and to use fecal microbiota transplantation (putting healthy bacteria from the intestine of the ill person) for people with multiple recurrences of C diff.


Story Source:

The above story is based on materials provided by University of Texas Health Science Center at Houston. Note: Materials may be edited for content and length.


Journal Reference:

  1. Herbert L. DuPont. Acute Infectious Diarrhea in Immunocompetent Adults. New England Journal of Medicine, 2014; 370 (16): 1532 DOI: 10.1056/NEJMra1301069

Cite This Page:

University of Texas Health Science Center at Houston. "179 million cases of acute diarrhea in U.S. each year, most preventable." ScienceDaily. ScienceDaily, 22 April 2014. <www.sciencedaily.com/releases/2014/04/140422113243.htm>.
University of Texas Health Science Center at Houston. (2014, April 22). 179 million cases of acute diarrhea in U.S. each year, most preventable. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/04/140422113243.htm
University of Texas Health Science Center at Houston. "179 million cases of acute diarrhea in U.S. each year, most preventable." ScienceDaily. www.sciencedaily.com/releases/2014/04/140422113243.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins